AVPC Molecular Signature Supplementary Figures from Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1. Supervised hierarchical clustering of differentially expressed genes between typical CRPC PDX ("ADENO") and CRPC PDX with small cell carcinoma morphology ("SCPC"). Supplementary Figure 2. Morphologic spectrum of tumors of patients with the aggressive variant phenotype in the primary (A-D) and metastatic tumor sites (E-H) Supplementary Figure 3. Immunohistochemical analysis of all 59 available NCT00514540 samples and 8 PDX lines. Supplementary Figure 4. Principal component analysis of a16-serum-and-IHC-tumor-marker set in "Baseline" samples from 21 patients. Supplementary Figure 5. Total number of copy number alterations per sample. Supplementary Figure 6. mRNA levels of genes of interest. Supplementary Figure 7. Principal component analysis of a 10-CNA-marker set in TCGA, unsupervised CRPC and AVPC samples.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362433292